In 1986, Procyte Corp. was founded as a Kirkland, Washington-based medical skin care company that developed and marketed therapeutic and daily use skincare and procedure-based products to dermatologists based on the company’s patented GHK Copper Peptide technology.

In 1996, the U.S. Food and Drug Administration approved the company’s Iamin gel wound dressing, a hydrogel for dressing and management of various types of wounds. On March 18, 2005, Procyte was acquired by PhotoMedex for $24.4 million. In 2016, PhotoMedex was subsequently acquired by DS Healthcare Group for $48 million

In 2018, Procyte’s co-founder Loren Pickart, Ph.D. received US patent 9,586,989 for “Non-toxic skin cancer therapy with copper peptides”.